LLY240816P440000
- 0.01
- -0.01-50.00%
Eli Lilly and Co Newsroom
Express News | Eli Lilly Files Pricing Term Sheet Related to Offering of Five-Part $5 Bln Aggregate Principal Amount of Notes - SEC Filing
Eli Lilly +5%, Named 'Top Pick' Following Q2 Beat Morgan Stanley Says
Don't Forget This Startup's Weight-Loss Pill, Analyst Says -- Barrons.com
Why Eli Lilly Is a Buy After Earnings. The Stock Got an Upgrade. -- Barrons.com
Weight Loss Drugs Like Ozempic, Zepbound May Reduce Cancer Risks, Studies Suggest
10 Health Care Stocks With Whale Alerts In Today's Session
Eli Lilly Tapping Bond Market for Morphic Deal -- Market Talk
Deutsche Bank: Eli Lilly (NYSE:LLY) Is a "High-Growth Unicorn"
Jim Cramer Considers Eli Lilly and Company (LLY) a 'Best of Breed' Stock
Eli Lilly To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Express News | Market-Moving News for August 12th
Express News | Eli Lilly Files for Five Part, Notes Offering; Size Not Disclosed - SEC Filing
Express News | Eli Lilly Shares Are Trading Higher After Deutsche Bank Upgraded the Stock From Hold to Buy and Raised Its Price Target From $725 to $1,025
Big Tech, Health-Care and High-Yield Stocks Are Dip-Buying Targets
Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
Eli Lilly Analyst Ratings
Stock Market Movers: KeyCorp, Monday.com, Starbucks, Barrick Gold, and More
Express News | Eli Lilly and Company : Deutsche Bank Raises to Buy From Hold
Express News | Eli Lilly and Company : Deutsche Bank Raises Target Price to $1025 From $725